article

Darifenacin (Enablex®, Novartis) is a medication used to treat urinary incontinence.

Darifenacin works by blocking the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions. It thereby decreases the urgency to urinate. It should not be used in people with urinary retention.

Administration


Darifenacin is administered as a once-daily extended-release oral tablet.

Side effects


Muscarinic antagonists

 

This article is licensed under the GNU Free Documentation License. It uses material from the "Darifenacin".

Home Pageartsbusinesscomputersgameshealthhospitalshomekids & teensnewsphysiciansrecreationreferenceregionalscienceshoppingsocietysportsworld